These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26993745)

  • 1. Discovery of novel N,N-3-phenyl-3-benzylaminopropionanilides as potent inhibitors of cholesteryl ester transfer protein in vivo.
    Xie H; Li Y; Bai C; Wang R; Liu C; Hao C; Lin B; Cheng M; Zhao D
    Bioorg Med Chem; 2016 Apr; 24(8):1811-8. PubMed ID: 26993745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor.
    Zhao D; Xie H; Bai C; Liu C; Hao C; Zhao S; Yuan H; Luo C; Wang J; Lin B; Zheng J; Cheng M
    Bioorg Med Chem; 2016 Apr; 24(8):1589-97. PubMed ID: 27010500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
    Chen D; Huang X; Zhou H; Luo H; Wang P; Chang Y; He X; Ni S; Shen Q; Cao G; Sun H; Wen X; Liu J
    Eur J Med Chem; 2017 Oct; 139():201-213. PubMed ID: 28802120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors.
    Wang X; Lin X; Xu X; Li W; Hao L; Liu C; Zhao D; Cheng M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29112169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of N,N-Substituted Amine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors.
    Wang X; Hao L; Xu X; Li W; Liu C; Zhao D; Cheng M
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28972557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
    Kalgutkar AS; Frederick KS; Hatch HL; Ambler CM; Perry DA; Garigipati RS; Chang GC; Lefker BA; Clark RW; Morehouse LA; Francone O; Hu X
    Xenobiotica; 2014 Jul; 44(7):591-605. PubMed ID: 24380613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.
    Jiang J; Finlay H; Johnson JA; Harikrishnan L; Kamau M; Qiao J; Wang T; Adam L; Taylor D; Yang R; Sleph P; Chen AYA; Yin X; Wexler R; Salvati ME
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3278-3281. PubMed ID: 27256912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G
    Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent cholesteryl ester transfer protein inhibitors of reduced lipophilicity: 1,1'-spiro-substituted hexahydrofuroquinoline derivatives.
    Trieselmann T; Wagner H; Fuchs K; Hamprecht D; Berta D; Cremonesi P; Streicher R; Luippold G; Volz A; Markert M; Nar H
    J Med Chem; 2014 Nov; 57(21):8766-76. PubMed ID: 25265559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
    Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma.
    Yamada K; Brousseau M; Honma W; Iimura A; Imase H; Iwaki Y; Kawanami T; LaSala D; Liang G; Mitani H; Nonomura K; Ohmori O; Pan M; Rigel DF; Umemura I; Yasoshima K; Zhu G; Mogi M
    J Med Chem; 2017 Oct; 60(20):8466-8481. PubMed ID: 29035537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel cholesteryl ester transfer protein inhibitors bearing a cycloalkene scaffold.
    Liu C; Luo C; Hao L; Wu Q; Xie H; Zhao S; Hao C; Zhao D; Cheng M
    Eur J Med Chem; 2016 Nov; 123():419-430. PubMed ID: 27490022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors.
    Chen C; Sun R; Sun Y; Chen X; Li F; Wen X; Yuan H; Chen D
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126824. PubMed ID: 31780304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.
    Castilho MS; Guido RV; Andricopulo AD
    Bioorg Med Chem; 2007 Sep; 15(18):6242-52. PubMed ID: 17604633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.
    Johns DG; Chen Y; Wang SP; Castro-Perez J; Previs SF; Roddy TP
    Eur J Pharmacol; 2015 Sep; 762():256-62. PubMed ID: 26049012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
    Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
    Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the discovery and development of cholesteryl ester transfer protein inhibitors for reducing residual cardiovascular risk.
    Mantlo NB; Escribano A
    J Med Chem; 2014 Jan; 57(1):1-17. PubMed ID: 23941686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors.
    Chang Y; Zhou S; Li E; Zhao W; Ji Y; Wen X; Sun H; Yuan H
    Eur J Med Chem; 2017 Jan; 126():143-153. PubMed ID: 27750148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    Abu Khalaf R; Abu Sheikha G; Bustanji Y; Taha MO
    Eur J Med Chem; 2010 Apr; 45(4):1598-617. PubMed ID: 20116902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.